Tag: Avandia

As of early 2024, the manufacturer of Avandia (rosiglitazone), Woodward Pharma Services, has stated that the controversial diabetes drug is no longer available in the United States. Its availability has been severely impacted by regulatory actions and safety concerns that arose over two decades, making the question of 'Is Avandia available in the US?' a complex one with a definitive modern answer.

In 2010, the diabetes drug Avandia was effectively banned in Europe and severely restricted in the U.S. due to mounting evidence linking it to an increased risk of serious cardiovascular events, including heart attacks and heart failure. This was the culmination of years of controversy and conflicting scientific findings regarding the safety of the once-popular medication.